Evidence-informed prioritization of interventions for integrating hypertension management into cardiovascular-kidney-metabolic care in primary health care: HEARTS 2.0 Phase 3
Authors:
- Pedro OrdunezPOPedro Ordunez
- Andres RosendeARAndres Rosende
- Maria Florencia Grande RattiMRMaria Florencia Grande Ratti
- Donald J DiPetteDDDonald J DiPette
- Ana Marcela TorresATAna Marcela Torres
- Esteban LondoñoELEsteban Londoño
- Sonia Y AngellSASonia Y Angell
- Mariana L Rodriguez de la CerdaMCMariana L Rodriguez de la Cerda
- Norm R C CampbellNCNorm R C Campbell
- Libardo Rodríguez MartínezLMLibardo Rodríguez Martínez
- Jeffrey BrettlerJBJeffrey Brettler
- Fernando TortosaFTFernando Tortosa
Top Cited Papers
Open Access
- 22 April 2026
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 39 (8) , 956-965
Abstract
Background: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative. This paper presents Phase 3 of HEARTS 2.0, an evidence-informed process to prioritize clinical and health-system interventions to support the operationalization of integrated cardiovascular, kidney, and metabolic (CKM) care in primary health care (PHC) and to inform the update of the HEARTS Clinical Pathway. CKM conditions frequently coexist, sharing common risk factors and pathophysiological mechanisms that exacerbate cardiovascular disease burden. Despite their overlap, clinical practice often remains siloed due to condition-specific guidelines, and its integration remains limited. To prioritize evidence-informed clinical and health-system interventions that support the operationalization of integrated CKM care within PHC and inform the update of the HEARTS Clinical Pathway. Methods: Building on previous phases of HEARTS 2.0, a multidisciplinary panel evaluated 45 candidate interventions in different areas. The selection process utilized structured evidence appraisal, Evidence-to-Decision frameworks, and a modified RAND/UCLA appropriateness method involving anonymized rating rounds. Results: A total of 38 interventions were prioritized for implementation. Although hypertension management remains the primary entry point, the resulting framework integrates early detection of diabetes and chronic kidney disease, lifestyle interventions, risk-based combination pharmacotherapy, task-sharing, and longitudinal follow-up. Conclusions: By translating dispersed guideline recommendations into implementable interventions, Phase 3 of HEARTS 2.0 provides an evidence-informed basis for advancing integrated CKM care at scale in PHC and guiding the forthcoming update of the HEARTS Clinical Pathway. The resulting framework offers a flexible, scalable approach for countries confronting similar epidemiological and health system challenges.Keywords
Funding Information
- Pan American Health Organization
- HEARTS in the Americas for Better Health Care for NCDs (607009)
This publication has 30 references indexed in Scilit:
- HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare—insights from HEARTS in the AmericasThe Lancet Regional Health - Americas, 2025
- Essential public health functions for primary health care resilience in Latin America and the Caribbean: a regional assessmentThe Lancet Regional Health - Americas, 2025
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsJACC, 2025
- Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionJACC, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension ControlCurrent Hypertension Reports, 2023
- Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income CountriesJACC, 2023
- Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation GroupThe Lancet Regional Health - Americas, 2022
- Guideline panels should not GRADE good practice statementsJournal of Clinical Epidemiology, 2015
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011